Soumit Roy
Stock Analyst at Jones Trading
(2.17)
# 2,856
Out of 4,964 analysts
42
Total ratings
19.35%
Success rate
0.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Initiates: Buy | $21 | $3.23 | +550.15% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $19.22 | +108.12% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $20.68 | +30.56% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.37 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $1.06 | - | 2 | May 16, 2025 | |
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.06 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $9.39 | +59.74% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $2.95 | +238.98% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $16.86 | +101.66% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $36 | $2.28 | +1,478.95% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.80 | +1,042.86% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.25 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $10.38 | -13.29% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $10.25 | +65.85% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.67 | +386.89% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.76 | +429.38% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.31 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.35 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.94 | +227.66% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $23.35 | +199.79% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $34.81 | -71.27% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.48 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $13.32 | +500.60% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.79 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $6.02 | +5,215.61% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $5.01 | +16,067.66% | 1 | Feb 24, 2021 |
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $3.23
Upside: +550.15%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $19.22
Upside: +108.12%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $20.68
Upside: +30.56%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.37
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.06
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.06
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $9.39
Upside: +59.74%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.95
Upside: +238.98%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $16.86
Upside: +101.66%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.28
Upside: +1,478.95%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.80
Upside: +1,042.86%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.25
Upside: -
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $10.38
Upside: -13.29%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $10.25
Upside: +65.85%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.67
Upside: +386.89%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.76
Upside: +429.38%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.31
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.35
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.94
Upside: +227.66%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $23.35
Upside: +199.79%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $34.81
Upside: -71.27%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.48
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $13.32
Upside: +500.60%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.79
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $6.02
Upside: +5,215.61%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $5.01
Upside: +16,067.66%